public health security

See the following -

A 'Very Graphic History' Of Germ Warfare

Press Release | Blue Ribbon Study Panel on Biodefense | April 25, 2019

Max Brooks, best-selling author of "World War Z" and non-resident fellow at the Modern War Institute at West Point, has partnered with the Blue Ribbon Study Panel on Biodefense to produce GERM WARFARE: A Very Graphic History. This highly stylized and engaging graphic novel, set for release this Saturday, depicts previous biological warfare events, the possibilities for the future, and the continued need for public health security. This is part of an effort by the bipartisan Panel to educate the public about biological risks and why a strong biodefense enterprise is critical to the health and security of the Nation.

Read More »

Blue Ribbon Study Panel Recognizes National Security Strategy, Calls for Comprehensive Approach

Press Release | Blue Ribbon Study Panel on Biodefense | December 21, 2017

Senator Joseph Lieberman and Governor Tom Ridge, the co-chairs of the Blue Ribbon Study Panel on Biodefense, today addressed the newly updated U.S. National Security Strategy and the emphasis it places on combatting biological threats to the country. “With the release of the National Security Strategy, the Administration is sending a strong message to our enemies that America takes the biological threat seriously,” said Sen. Lieberman and Gov. Ridge.

Read More »

Congress Passes Legislation Authorizing Critical Biodefense Programs

Press Release | Blue Ribbon Study Panel on Biodefense | June 5, 2019

The House yesterday passed the Pandemic and All-Hazards Preparedness and Advancing Innovation Act. The bill reauthorizes existing statute governing public health efforts at the Department of Health and Human Services. Additions made by the bill - some of which were recommended by the Blue Ribbon Study Panel on Biodefense - address biodetection, hospital preparedness, medical countermeasures and response. Many of these programs will enable HHS to better defend the nation against biological threats. Both chambers of Congress have passed the bill, and it will now go to President Trump for signature.

Read More »

Experts support a future Manhattan Project for Biodefense to thwart new threats

Kim Riley | Homeland Preparedness News | July 12, 2019

An effort similar to the Manhattan Project - in which American-led R&D produced the first nuclear weapons during World War II - is needed now in defense against the growing global threats posed by infectious diseases and bioterrorism, sources said Thursday during a Blue Ribbon Study Panel on Biodefense meeting...witness panelists and attendees at the panel's first public meeting held yesterday in New York City discussed "A Manhattan Project for Biodefense: Taking Biological Threats Off the Table," a proposed national, public-private research and development undertaking that would defend the United States against biological threats.

Read More »

Pandemic and all-hazards preparedness, response law emboldens U.S. disaster recovery efforts

Kim Reilly | Homeland Preparedness News | June 25, 2019

The Pandemic and All-Hazards Preparedness and Advancing (PAHPA) Innovation Act, S. 1379, became law on Monday with the president's signature, prompting accolades from national stakeholders, company executives and federal lawmakers. The far-reaching law ensures the United States will be better prepared to respond to a wide range of public health emergencies, whether man-made or occurring through a natural disaster or infectious disease. Overall, the law aims to bolster the nation's health security strategy, strengthen the country's emergency response workforce, prioritize a threat-based approach, and increase communication across the advanced research and development of medical countermeasures (MCMs), among numerous provisions contained in the law.

Read More »

Panel To Discuss 'A Manhattan Project For Biodefense' At NYC Public Meeting

Press Release | Blue Ribbon Study Panel on Biodefense | July 8, 2019

The bipartisan Blue Ribbon Study Panel on Biodefense will host its first-ever public meeting in New York City this Thursday, July 11, to discuss A Manhattan Project for Biodefense - a national, public-private research and development undertaking to defend the U.S. against biological threats. These threats include biological warfare and bioterrorism, where nation-states or terror groups intentionally spread biological agents to cause widespread panic and harm, as well as infectious disease pandemics.

Read More »